Obviously stung by international condemnation of trade in exotic animals and derived products for traditional Chinese medicines, the central government removed pangolin scales from the list of approved ingredients.  Demonstrating that pangolins are susceptible to a coronavirus similar to SARS-CoV-2 justified the decision.  Now China must seriously evaluate the pharmacologic benefits of animal-derived products in their traditional medicine pharmacopoeia and remove any items derived from wildlife.